Table 5.
Outcome | Ticagrelor/Aspirin N (%) (N = 197) | Clopidogrel/Aspirin N (%) (N = 190) | HR (95%CI) | P value | Adjusted HR (95%CI)# | P value |
---|---|---|---|---|---|---|
Efficacy outcome | ||||||
Stroke | 9(4.6) | 18(9.5) | 0.47(0.21–1.05) | 0.06 | 0.47(0.21–1.04) | 0.06 |
Composite vascular events | 10(5.1) | 20(10.5) | 0.47(0.22–1.00) | 0.050 | 0.47(0.22–1.00) | 0.049 |
Ischemic stroke | 7(3.6) | 17(9.0) | 0.39(0.16–0.93) | 0.03 | 0.38(0.16–0.92) | 0.03 |
Safety outcome | ||||||
Major bleeding | 2(1.0) | 2(1.1) | 0.97(0.14–6.87) | 0.97 | 1.02(0.14–7.29) | 0.98 |
Any Bleeding | 39(19.8) | 25(13.2) | 1.57(0.95–2.59) | 0.08 | 1.57(0.95–2.60) | 0.08 |
CI indicates confidence interval.
Adjusted for age and sex.